EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of Red Blood Cell Transfusion on Inflammatory and Angiogenic Pathways in Patients With Sickle Cell Disease

Lydian A de Ligt iD, Sanjay R Thakoerdin, Maud Zwolsman, Gaby Stegemann, Hanke Matlung, Taco W Kuijpers, Bart J Biemond, Karin Fijnvandraat iD, Robin van Bruggen, Erfan Nur iD

American Journal of Hematology · 2026

DOI: 10.1002/ajh.70193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hematology, 2026. Verfasst von Lydian A de Ligt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sanquin Research and Landsteiner Laboratory, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Erythrocyte Transfusion, Angiogenic Proteins. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study was funded by a Dutch government transfusion-related grant to Sanquin Research..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell disease (SCD) is a chronic inflammatory state, characterized by increased plasma values of inflammatory and angiogenic proteins. Although red blood cell (RBC) transfusion is known to have immunomodulatory effects in other conditions, its potential effects on the inflammatory state in SCD remain largely unknown. This study aimed to explore the longitudinal effects of RBC transfusion on plasma inflammatory and angiogenic proteins in chronically transfused patients with SCD. Plasma samples were collected from SCD patients treated with either exchange ( N = 12) or top‐up ( N = 12) transfusion prior to transfusion and 1 h, 24–72 h, 1 and 2 weeks post‐transfusion. Proximity Extension Assay technology was used to measure plasma values of 21 proteins at each of these timepoints. Exchange transfusion resulted in decreased values of proteins released during inflammasome activation (IL‐1β, IL‐18), B cell survival and activation (TNFRSF13B/TACI, TNFRSF13C/BAFFR, TNFSF13/APRIL), angiogenesis (ANGPT2, VEGFA, KDR, CXCL12), and neutrophil differentiation, recruitment and activation (G‐CSF, G‐CSFR, CXCL1, CXCL5, CXCL6), at 1 h post‐transfusion, returning gradually to values comparable to pre‐transfusion values during 2 weeks post‐transfusion. In contrast, top‐up transfusion resulted in increased values of EPO and ANGPT1. While exchange transfusion seems to reduce the activation of pro‐inflammatory and pro‐angiogenic pathways, top‐up transfusion might result in reduced hypoxia and increased vascular stability as suggested by the increased values of EPO and ANGPT1. These results enhance our understanding of the effects of RBC transfusion on inflammatory and angiogenic pathways and suggest that exchange transfusion has a stronger effect on these pathways in SCD patients compared to top‐up transfusion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellErythrocyte TransfusionAngiogenic ProteinsHumansAdultFemaleMaleInflammationYoung AdultMiddle AgedAdolescent

Stichwörter der Autor:innen

inflammationproteomicssickle cell diseasetransfusion

Substanzen

Angiogenic Proteins

Autor:innen und Institutionen

  • Sanquin Research and Landsteiner Laboratory, Amsterdam, the Netherlands.
  • Department of Hematology, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Pediatric Hematology, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Pediatric Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.

ORCID-Profile: Lydian A de Ligt, Karin Fijnvandraat, Erfan Nur

Förderung

  • This study was funded by a Dutch government transfusion-related grant to Sanquin Research.

Zitieren

APA

de Ligt, L. A., Thakoerdin, S. R., Zwolsman, M., Stegemann, G., Matlung, H., Kuijpers, T. W., Biemond, B. J., Fijnvandraat, K., van Bruggen, R., & Nur, E. (2026). Effect of Red Blood Cell Transfusion on Inflammatory and Angiogenic Pathways in Patients With Sickle Cell Disease. American Journal of Hematology. https://doi.org/10.1002/ajh.70193

Vancouver

de Ligt LA, Thakoerdin SR, Zwolsman M, Stegemann G, Matlung H, Kuijpers TW, et al. Effect of Red Blood Cell Transfusion on Inflammatory and Angiogenic Pathways in Patients With Sickle Cell Disease. American Journal of Hematology. 2026. doi:10.1002/ajh.70193

BibTeX
@article{deLigt2026,
  author = {de Ligt, Lydian A and Thakoerdin, Sanjay R and Zwolsman, Maud and Stegemann, Gaby and Matlung, Hanke and Kuijpers, Taco W and Biemond, Bart J and Fijnvandraat, Karin and van Bruggen, Robin and Nur, Erfan},
  title = {Effect of Red Blood Cell Transfusion on Inflammatory and Angiogenic Pathways in Patients With Sickle Cell Disease},
  journal = {American Journal of Hematology},
  year = {2026},
  doi = {10.1002/ajh.70193}
}
Kostenlos starten →